Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of CBL-514 for cellulite (Stage 2) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellulite

Drugs mentioned

• CBL-514

Snippet

Sponsor: Caliway Biopharmaceuticals Co., Ltd. | Conditions: Cellulite | Phase 2 | Status: COMPLETED | Results posted: 2026-07-09